CAMECO CORP (CCJ)

CA13321L1085 - Common Stock

60.93  +3.32 (+5.76%)

Premarket: 60.97 +0.04 (+0.07%)

Fundamental Rating

4

CCJ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 204 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of CCJ is average, but there are quite some concerns on its profitability. CCJ is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year CCJ was profitable.
CCJ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CCJ reported negative net income in multiple years.
Each year in the past 5 years CCJ had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of 1.25%, CCJ is not doing good in the industry: 73.40% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 1.88%, CCJ is doing worse than 72.91% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.95%, CCJ is doing worse than 73.89% of the companies in the same industry.
Industry RankSector Rank
ROA 1.25%
ROE 1.88%
ROIC 2.95%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CCJ's Profit Margin of 4.17% is on the low side compared to the rest of the industry. CCJ is outperformed by 67.00% of its industry peers.
CCJ's Profit Margin has improved in the last couple of years.
CCJ's Operating Margin of 12.49% is on the low side compared to the rest of the industry. CCJ is outperformed by 62.56% of its industry peers.
CCJ's Operating Margin has improved in the last couple of years.
CCJ's Gross Margin of 23.81% is on the low side compared to the rest of the industry. CCJ is outperformed by 66.01% of its industry peers.
In the last couple of years the Gross Margin of CCJ has grown nicely.
Industry RankSector Rank
OM 12.49%
PM (TTM) 4.17%
GM 23.81%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CCJ is destroying value.
The number of shares outstanding for CCJ has been increased compared to 1 year ago.
CCJ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCJ has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 8.23 indicates that CCJ is not in any danger for bankruptcy at the moment.
CCJ has a Altman-Z score of 8.23. This is amongst the best in the industry. CCJ outperforms 91.63% of its industry peers.
CCJ has a debt to FCF ratio of 3.27. This is a good value and a sign of high solvency as CCJ would need 3.27 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.27, CCJ is doing good in the industry, outperforming 67.49% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that CCJ is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, CCJ is doing good in the industry, outperforming 67.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Altman-Z 8.23
ROIC/WACC0.39
WACC7.62%

2.3 Liquidity

CCJ has a Current Ratio of 2.88. This indicates that CCJ is financially healthy and has no problem in meeting its short term obligations.
CCJ has a Current ratio of 2.88. This is in the better half of the industry: CCJ outperforms 79.31% of its industry peers.
A Quick Ratio of 1.26 indicates that CCJ should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.26, CCJ is in the better half of the industry, outperforming 64.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.26

5

3. Growth

3.1 Past

The earnings per share for CCJ have decreased strongly by -30.43% in the last year.
CCJ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.91% yearly.
CCJ shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.31%.
Measured over the past years, CCJ shows a small growth in Revenue. The Revenue has been growing by 4.35% on average per year.
EPS 1Y (TTM)-30.43%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%-104.34%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%25.32%

3.2 Future

The Earnings Per Share is expected to grow by 28.74% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.44% on average over the next years.
EPS Next Y8.28%
EPS Next 2Y43.98%
EPS Next 3Y40.83%
EPS Next 5Y28.74%
Revenue Next Year18.73%
Revenue Next 2Y13.41%
Revenue Next 3Y10.76%
Revenue Next 5Y5.44%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

CCJ is valuated quite expensively with a Price/Earnings ratio of 184.64.
Based on the Price/Earnings ratio, CCJ is valued a bit more expensive than 76.85% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.96. CCJ is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 51.96, the valuation of CCJ can be described as expensive.
CCJ's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CCJ is more expensive than 70.94% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CCJ to the average of the S&P500 Index (23.82), we can say CCJ is valued expensively.
Industry RankSector Rank
PE 184.64
Fwd PE 51.96

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCJ is valued more expensive than 80.30% of the companies in the same industry.
63.55% of the companies in the same industry are cheaper than CCJ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 95.93
EV/EBITDA 66.65

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CCJ's earnings are expected to grow with 40.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)22.31
PEG (5Y)23.35
EPS Next 2Y43.98%
EPS Next 3Y40.83%

3

5. Dividend

5.1 Amount

CCJ has a yearly dividend return of 0.21%, which is pretty low.
CCJ's Dividend Yield is slightly below the industry average, which is at 6.45.
Compared to an average S&P500 Dividend Yield of 2.23, CCJ's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.21%

5.2 History

The dividend of CCJ decreases each year by -7.75%.
CCJ has paid a dividend for at least 10 years, which is a reliable track record.
CCJ has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-7.75%
Div Incr Years0
Div Non Decr Years5

5.3 Sustainability

CCJ pays out 44.71% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP44.71%
EPS Next 2Y43.98%
EPS Next 3Y40.83%

CAMECO CORP

NYSE:CCJ (11/21/2024, 8:18:17 PM)

Premarket: 60.97 +0.04 (+0.07%)

60.93

+3.32 (+5.76%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap26.52B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.21%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 184.64
Fwd PE 51.96
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)22.31
PEG (5Y)23.35
Profitability
Industry RankSector Rank
ROA 1.25%
ROE 1.88%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.49%
PM (TTM) 4.17%
GM 23.81%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.88
Quick Ratio 1.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-30.43%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y8.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)23.31%
Revenue growth 3Y12.86%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y